About International Stemcell Services
International Stemcell Services is a company based in Bengaluru (India) founded in 2008. International Stemcell Services has raised $84.18 thousand across 1 funding round from investors including HCG. International Stemcell Services offers products and services including Stem Cell Banking, Cord Blood Banking, Cellular Therapy, and Platelet Rich Plasma (PRP). International Stemcell Services operates in a competitive market with competitors including Cordlife, LifeCell, ViaCord, Esperite and CORD:USE Cord Blood, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Icrest Biotechnologies Limited
- Date of Incorporation 17 Sep, 2008
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$84.61 K (USD)14.71as on Mar 31, 2022
-
Net Profit
-$13.95 K (USD)44.29as on Mar 31, 2022
-
EBITDA
-$14.24 K (USD)-158.97as on Mar 31, 2022
-
Total Equity Funding
$84.18 K (USD)
in 1 rounds
-
Latest Funding Round
$84.18 K (USD), Seed
May 01, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of International Stemcell Services
International Stemcell Services offers a comprehensive portfolio of products and services, including Stem Cell Banking, Cord Blood Banking, Cellular Therapy, and Platelet Rich Plasma (PRP).
Secure storage of stem cells for future medical use and treatments.
Preserves umbilical cord blood for potential regenerative therapies.
Applies stem cells to treat conditions like cancer and vascular diseases.
Uses PRP for applications in hair loss and tissue regeneration.
Funding Insights of International Stemcell Services
International Stemcell Services has successfully raised a total of $84.18K through 1 strategic funding round. The most recent funding activity was a Seed round of $84.18 thousand completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in International Stemcell Services
International Stemcell Services has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HCG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chain of oncology hospitals
|
Locked | Locked | Locked |
Investor details for International Stemcell Services
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by International Stemcell Services
Investment portfolio details for International Stemcell Services
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - International Stemcell Services
Detailed financials for International Stemcell Services
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
International Stemcell Services Comparisons
Peer comparison for International Stemcell Services
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of International Stemcell Services
International Stemcell Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cordlife, LifeCell, ViaCord, Esperite and CORD:USE Cord Blood, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cordlife is engaged in cord blood banking and diagnostics.
|
|
| Locked | Locked | Locked |
LifeCell is engaged in cord blood banking services.
|
|
| Locked | Locked | Locked |
Provider of services for cord blood and stem cell banking
|
|
| Locked | Locked | Locked |
Umbilical cord blood stem cells are collected, processed, and stored.
|
|
| Locked | Locked | Locked |
Provider of umbilical cord blood stem cell storage services
|
|
| Locked | Locked | Locked |
Offers stem cell banking services for cord blood and cord lining storage globally.
|
Detailed competitors of International Stemcell Services
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on International Stemcell Services
Complete news archive for International Stemcell Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about International Stemcell Services
International Stemcell Services was founded in 2008 and raised its 1st funding round 10 years after it was founded.
International Stemcell Services is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
International Stemcell Services is a funded company, having raised a total of $84.18K across 1 funding round to date.
Annual revenue of International Stemcell Services is $84.61K as on Mar 31, 2022.
International Stemcell Services was founded in 2008 in Bengaluru, India, within the biotechnology sector focused on stem cell preservation. Stem cells are sourced from bone marrow, adipose tissue, umbilical cord blood, and dental pulp. These are processed and stored to support potential therapies for chronic conditions, including cancer. Operations emphasize secure, long-term cryopreservation services for medical applications.
International Stemcell Services offers Stem Cell Banking, Cord Blood Banking, Cellular Therapy, and Platelet Rich Plasma (PRP).
International Stemcell Services has 1 investor. Key investors include HCG.